Education Archive

Evidence for regression of CIN2

New evidence from the ALTS trial suggests that 40% of CIN 2 will regress over 2 years, but CIN 2 caused by HPV-16 may be less likely to regress than CIN 2 caused by other high-risk-HPV genotypes.



http://ppv.ovid.com/pt/re/ppv/abstract.00006250-200901000-00006.htmjsessionid=JRxFybLNMtW2bTj3zCt5tJvKNJYvcnzQM48G2yXW3s6LtnyTrDlm!-1757429973!181195628!8091!-1